EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische StudieOpen Access

Generative chromoendoscopy for gastric neoplasms: a multicenter prospective study

Sho Suzuki iD, Yusuke Monno, Hiroyuki Yamamoto, Ayaka Takasu iD, Toshiaki Hirasawa, Toshihiro Nishizawa iD, Shun Ito, Fumiaki Ishibashi iD, Masatoshi Okutomi, Tomohiro Tada

Endoscopy · 01.08.2026 · 58 (08) · 848-855

DOI: 10.1055/a-2873-4466 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.08.2026. Verfasst von Sho Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: International University of Health and Welfare Ichikawa Hospital, Department of Gastroenterology, Chiba, Japan, Ichikawa. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastroscopy, Adenoma, Image Enhancement. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development (AMED, Japan Society for the Promotion of Science (JSPS) KAKENHI, Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Generative indigo carmine chromoendoscopy (generative chromoendoscopy), produced using deep learning-based synthetic image transformation, is a novel image-enhanced endoscopic approach, whose clinical feasibility has not been validated. This proof-of-concept study evaluated whether generative chromoendoscopy improves the visibility of gastric neoplasms compared with conventional white-light imaging (WLI) and real chromoendoscopy.

Methods

This prospective multicenter study was conducted at three Japanese institutions between January and August 2025. A deep neural network-based program converted WLI into generative chromoendoscopy images. Patients with early gastric cancer or adenoma sequentially underwent endoscopy using WLI, generative chromoendoscopy, and real chromoendoscopy. During live endoscopy, two endoscopists independently assessed lesion visibility using a 7-point Likert-type scale (−3 to +3). The primary end point was visibility of gastric neoplasms with generative chromoendoscopy relative to WLI, with comparison to real chromoendoscopy. Secondary end points included clinicopathologic factors associated with improved visibility.

Results

60 patients were included. Mean (SD) visibility scores were 0.67 (0.93) for generative chromoendoscopy and 0.51 (1.00) for real chromoendoscopy. The mean difference was 0.16 (95%CI 0.01 to 0.30). Differentiated-type histology (odds ratio [OR] 2.19, 95%CI 1.03 to 4.62), current Helicobacter pylori infection (OR 2.14, 95%CI 1.02 to 4.46), and expert endoscopist status (OR 2.14, 95%CI 1.22 to 3.76) were significantly associated with higher visibility scores using generative chromoendoscopy.

Conclusions

Generative chromoendoscopy was feasible during live endoscopic procedures. It improved visibility of pre-identified gastric neoplasms compared with WLI and achieved visibility comparable to real chromoendoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastroscopyAdenomaImage EnhancementHumansProspective StudiesIndigo CarmineFemaleMaleColoring AgentsAgedMiddle AgedDeep LearningGenerative Artificial Intelligence

Substanzen

Indigo CarmineColoring Agents

Autor:innen und Institutionen

  • International University of Health and Welfare Ichikawa Hospital, Department of Gastroenterology, Chiba, Japan, Ichikawa.
  • International University of Health and Welfare, Faculty of Medicine, Graduate School of Medicine, Japan, Narita.
  • Institute of Science Tokyo, Department of Systems and Control Engineering, School of Engineering, Japan, Tokyo.
  • Cancer Institute Hospital, Japanese Foundation for Cancer Research, Department of Gastroenterology, Japan, Tokyo.
  • International University of Health and Welfare Narita Hospital, Department of Gastroenterology, Japan, Narita.
  • AI Medical Service Inc., Japan, Tokyo.

ORCID-Profile: Sho Suzuki, Ayaka Takasu, Toshihiro Nishizawa, Fumiaki Ishibashi

Förderung

  • Japan Agency for Medical Research and Development (AMED
  • Japan Society for the Promotion of Science (JSPS) KAKENHI
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Suzuki, S., Monno, Y., Yamamoto, H., Takasu, A., Hirasawa, T., Nishizawa, T., Ito, S., Ishibashi, F., Okutomi, M., & Tada, T. (2026). Generative chromoendoscopy for gastric neoplasms: a multicenter prospective study. Endoscopy, 58(08), 848-855. https://doi.org/10.1055/a-2873-4466

Vancouver

Suzuki S, Monno Y, Yamamoto H, Takasu A, Hirasawa T, Nishizawa T, et al. Generative chromoendoscopy for gastric neoplasms: a multicenter prospective study. Endoscopy. 2026;58(08):848-855. doi:10.1055/a-2873-4466

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Sho and Monno, Yusuke and Yamamoto, Hiroyuki and Takasu, Ayaka and Hirasawa, Toshiaki and Nishizawa, Toshihiro and Ito, Shun and Ishibashi, Fumiaki and Okutomi, Masatoshi and Tada, Tomohiro},
  title = {Generative chromoendoscopy for gastric neoplasms: a multicenter prospective study},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {08},
  pages = {848--855},
  doi = {10.1055/a-2873-4466}
}
Kostenlos starten →